Table 3 Association of disease control with anamorelin efficacy (n = 44)
From: Real-world data of anamorelin in advanced gastrointestinal cancer patients with cancer cachexia
Disease control | ANAM Responder | ANAM Non-responder | Odds ratio | |
|---|---|---|---|---|
(n = 28) | (n = 16) | |||
Yes, n (%) | 21 (75.0) | 6 (37.5) | 4.80 (95% CI: 1.11–23.20) p = 0.0238 | |
No, n (%) | 7 (25.0) | 10 (62.5) |